Literature DB >> 15942417

Trends in coronary heart disease in France during the second half of the 1990s.

Dominique Arveiler1, Aline Wagner, Pierre Ducimetière, Michèle Montaye, Jean-Bernard Ruidavets, Annie Bingham, Jean Ferrières, Philippe Amouyel, Bernadette Haas.   

Abstract

BACKGROUND: Data on the recent evolution in coronary heart disease (CHD) mortality and incidence rates are lacking in France. This paper aims to investigate whether the declining trends observed from 1985-1993 still persist in the second half of the 1990s.
METHODS: Population registers of acute CHD have been implemented in three specific geographical areas, first as part of the MONICA Project (1985-1993) and, since 1997, according to a simplified registration procedure. Weighted Poisson regressions have been used to investigate time trends in CHD events in men and women aged 35-64 after correction for registration differences.
RESULTS: Data obtained from 1997-2000 showed that the north-to-south gradient of decreasing frequency of CHD events in France was still present. Besides, they revealed no specific trend in CHD morbidity by centre and gender, except in Lille (in the north of France) where events tended to increase in women. Coronary heart disease mortality rates in recent years were decreasing in men, particularly in the north and east of France, but were stable in women with, even, a rising tendency in the north.
CONCLUSION: The decreasing trend in CHD events in France observed from the mid 1980s to the early 1990s seemed to markedly slow down in the second half of the 1990s.

Entities:  

Mesh:

Year:  2005        PMID: 15942417     DOI: 10.1097/01.hjr.0000160603.49386.92

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  5 in total

1.  Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users.

Authors:  David Laharie; Cécile Droz-Perroteau; Jacques Bénichou; Michel Amouretti; Patrick Blin; Bernard Bégaud; Estelle Guiard; Sylvie Dutoit; Stéphanie Lamarque; Yola Moride; Fanny Depont; Annie Fourrier-Réglat; Nicholas Moore
Journal:  Br J Clin Pharmacol       Date:  2010-03       Impact factor: 4.335

2.  Levels and trends in cardiovascular risk factors and drug treatment in 4837 elderly Dutch myocardial infarction patients between 2002 and 2006.

Authors:  S S Soedamah-Muthu; J M Geleijnse; E J Giltay; J de Goede; L M Oude Griep; E Waterham; A M Teitsma-Jansen; B J M Mulder; M-J de Boer; J W Deckers; P L Zock; D Kromhout
Journal:  Neth Heart J       Date:  2012-02-08       Impact factor: 2.380

3.  Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status.

Authors:  Aliou Baldé; Sylvie Lang; Aline Wagner; Jean Ferrières; Michèle Montaye; Pierre Tattevin; Laurent Cotte; Elisabeth Aslangul; Frédéric Bidégain; Antoine Chéret; Murielle Mary-Krause; Jean-Luc Meynard; Jean-Michel Molina; Marialuisa Partisani; Pierre-Marie Roger; Franck Boccara; Dominique Costagliola
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

4.  Comparison of clinical profiles and care for patients with incident versus recurrent acute coronary syndromes in France: Data from the MONICA registries.

Authors:  Suzanne Machta; Victoria Gauthier; Jean Ferrières; Michèle Montaye; Samantha Huo Yung Kai; Stefy Gbokou; Katia Biasch; Marie Moitry; Philippe Amouyel; Jean Dallongeville; Aline Meirhaeghe
Journal:  PLoS One       Date:  2022-02-14       Impact factor: 3.240

5.  Triptan use and risk of cardiovascular events: a nested-case-control study from the French health system database.

Authors:  S Lugardon; H Roussel; V Sciortino; J L Montastruc; M Lapeyre-Mestre
Journal:  Eur J Clin Pharmacol       Date:  2007-06-19       Impact factor: 3.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.